Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2024-12-27
DOI
https://doi.org/10.1016/j.ebiom.2024.105511
Citations
6
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

Anders Benjamin Kildal, Sarah Louise Murphy, Fridtjof Lund‐Johansen, Sophie Trouillet‐Assant et al.
6 citations
EBioMedicine
COVID-19 Clinical Research Studies
2.33
article

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

Anders Benjamin Kildal, Sarah Louise Murphy, Fridtjof Lund‐Johansen, Sophie Trouillet‐Assant, Yoann Zerbib, José Ramón Arribas, Bente Lise Halvorsen, Maude Bouscambert‐Duchamp, Saad Aballi, Jannicke Horjen Møller, Amin Alirezaylavasani, Dominique G. Costagliola, Lucie de Gastines, Lars Heggelund, Lionel Piroth, Nuriye Basdag Tekin, Kristian Tonby, César Vieira, Jean‐François Timsit, Olav Dalgård, Hafid Ait‐Oufella, Inge Christoffer Olsen, Hassen Kared, Ludvig A. Munthe, Vegard Skogen, Thor Ueland, Alpha Diallo, Pål Aukrust, Benjamin Dervieux, Anne Ma Dyrhol‐Riise, Damien Roux, Renaud Prével, Jean‐Christophe Richard, Marius Trøseid, Anders Aune Tveita, Annika E. Michelsen, Aleksander Rygh Holten, Tuva Børresdatter Dahl, Lambert Assoumou, Hans‐Kittil Viermyr, Erica Ponzi, Virginie Dyon-Tafani, Joy Mootien, Nathan Peiffer-Smadja, Yazdan Yazdanpanah, Karl Erik Müller, Denis Malvy, Julien Poissy, Jonas Daniel Sjøberg Øgaard
article en
6 citations

Abstract

No abstract available for this paper.
EBioMedicineVol. 111
Université Claude Bernard Lyon 1 (FR), Délégation Paris 5 (FR), École Normale Supérieure de Lyon (FR), Oslo University Hospital (NO), Centre National de la Recherche Scientifique (FR), University Hospital of North Norway (NO), Université de Bordeaux (FR), Inserm (FR), Délégation Paris 7 (FR), University of Oslo (NO), Université Paris Cité (FR), Stavanger University Hospital (NO), Akershus University Hospital (NO), Vestre Viken Hospital Trust (NO), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Hôpital Louis-Mourier (FR), Hôpital de la Croix-Rousse (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hôpital Saint-Antoine (FR), Bordeaux Population Health (FR), Centro de Investigación Biomédica en Red (ES), Unité de Glycobiologie Structurale et Fonctionnelle (FR), Centre d'Immunologie et des Maladies Infectieuses (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Centre de Recherche Saint-Antoine (FR), Hospital Curry Cabral (PT), Virologie et Pathologies Humaines (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Hôpital Bichat-Claude-Bernard (FR), Groupe Hospitalier de la Région de Mulhouse et Sud Alsace (FR), Centre de Recherche Cardio-Thoracique de Bordeaux (FR), Østfold Hospital Trust (NO), Centre International de Recherche en Infectiologie (FR), Institut de Recherche pour le Développement (FR), University of Bergen (NO)
Amgen, Eli Lilly and Company, Pfizer, Gilead Sciences, ViiV Healthcare, Moderna, Universitetet i Oslo, Norges Forskningsråd, Shionogi, Helse Sør-Øst RHF
Openalex Percentile: Top 11%
COVID-19 Clinical Research Studies
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.